ReGENE LLC

About

ReGENE LLS is developing small-molecule drugs to target core mechanisms of aging and longevity with a specific focus on Alzheimer’s disease. ReGENE developed early lead compounds and demonstrated their efficacy and safety in rodent studies. Currently, we are looking for proceeds to conduct lead optimization, grow the team, strengthen operations, fuel R&D, and IP protection.